AI MARKET SCANNING

$HYL.BR

🔒 Europe

Hyloris Pharmaceuticals SA

🏛️ EURONEXT BRUSSELS 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -2.07%
MAX GAP RECORD -2.18%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $HYL.BR
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Sep 24, 2026 Earnings Release 2026-09-24 (AFTER CLOSE (17:00))
-1.96%
Mar 26, 2026 Earnings Release 2026-03-26 (BEFORE OPEN)
-2.18%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.1%
Bullish Gaps (0)
Bearish Gaps (2)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $HYL.BR

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Hyloris Pharmaceuticals SA engages in the provision of development and reformulating of pharmaceutical products. It offers commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a novel, dual modeof-action non-opioid analgesic for the treatment of post-operative pain. The company was founded by Stijn van Rompay and…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗